Skip to content

NUVASIVE INC

Delisted

CIK 1142596fmd_1XFT3NW4MNRY16Z1QR5MRVFBBHManufacturing · Surgical & Medical Instruments & ApparatusTemplate: Standard

Coverage: Jan 01, 2008 to Jun 30, 2023, 58 periods

Latest annual · FY2022

Millions
Total revenues
1,202
Gross profit
865
Operating income
88
Net income
40
Free cash flow
30

Latest quarter · Q2 FY2023

Millions
Total revenues
318
Gross profit
228
Operating income
18
Net income
7
Free cash flow
3
Open Financials

Key stats

Open Analysis

Compound annual growth

Revenue, 3 yearsFY2019 to FY2022
+1.0%
Revenue, 5 yearsFY2017 to FY2022
+3.2%
Net income, 5 yearsFY2017 to FY2022
-13.1%

NUVASIVE INC financials: quick answers

Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.

MetricFY2022FY2021ChangeSource
Revenue$1.2 billion$1.1 billion+5.5%10-K 2023-02-22 · proof
Gross profit$865.4 million$816.7 million+6%10-K 2023-02-22 · proof
Operating income$88.4 million-$12 million10-K 2023-02-22 · proof
Net income$40.4 million-$64.1 million10-K 2023-02-22 · proof
Cash from operating activities$169.1 million$182.2 million-7.2%10-K 2023-02-22 · proof
Free cash flow$29.9 million$71.1 million-57.9%10-K 2023-02-22 · proof
Total assets$2.2 billion$2.2 billion+3.3%10-K 2023-02-22 · proof
Total liabilities$1.4 billion$1.4 billion-0.2%10-K 2023-02-22 · proof
Cash and cash equivalents$248.7 million$246.1 million+1%10-K 2023-02-22 · proof
What was NUVASIVE INC's revenue in fiscal 2022?
NUVASIVE INC reported revenue of $1.2 billion for fiscal 2022 (the year ended Dec 31, 2022), against $1.1 billion the year before (+5.5%). Source: the 10-K filed with the SEC on Feb 22, 2023. SEC
What was NUVASIVE INC's gross profit in fiscal 2022?
NUVASIVE INC reported gross profit of $865.4 million for fiscal 2022 (the year ended Dec 31, 2022), against $816.7 million the year before (+6%). Source: the 10-K filed with the SEC on Feb 22, 2023. SEC
What was NUVASIVE INC's operating income in fiscal 2022?
NUVASIVE INC reported operating income of $88.4 million for fiscal 2022 (the year ended Dec 31, 2022), against -$12 million the year before. Source: the 10-K filed with the SEC on Feb 22, 2023. SEC
What was NUVASIVE INC's net income in fiscal 2022?
NUVASIVE INC reported net income of $40.4 million for fiscal 2022 (the year ended Dec 31, 2022), against -$64.1 million the year before. Source: the 10-K filed with the SEC on Feb 22, 2023. SEC
What was NUVASIVE INC's cash from operating activities in fiscal 2022?
NUVASIVE INC reported cash from operating activities of $169.1 million for fiscal 2022 (the year ended Dec 31, 2022), against $182.2 million the year before (-7.2%). Source: the 10-K filed with the SEC on Feb 22, 2023. SEC
What was NUVASIVE INC's free cash flow in fiscal 2022?
NUVASIVE INC reported free cash flow of $29.9 million for fiscal 2022 (the year ended Dec 31, 2022), against $71.1 million the year before (-57.9%). Source: the 10-K filed with the SEC on Feb 22, 2023. SEC
What are NUVASIVE INC's total assets?
As of Dec 31, 2022, NUVASIVE INC reported total assets of $2.2 billion, against $2.2 billion a year earlier (+3.3%). Source: the 10-K filed with the SEC on Feb 22, 2023. SEC
What are NUVASIVE INC's total liabilities?
As of Dec 31, 2022, NUVASIVE INC reported total liabilities of $1.4 billion, against $1.4 billion a year earlier (-0.2%). Source: the 10-K filed with the SEC on Feb 22, 2023. SEC
What are NUVASIVE INC's cash and cash equivalents?
As of Dec 31, 2022, NUVASIVE INC reported cash and cash equivalents of $248.7 million, against $246.1 million a year earlier (+1%). Source: the 10-K filed with the SEC on Feb 22, 2023. SEC

Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.

The same numbers for an agent, with proof on every value:

curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:1142596&period_type=annual&limit=5"

Information only, not investment advice.